Abiopharma

FDA approve SITAGLIPTIN

New Form S-1/A - AETHLON MEDICAL INC Filed: 2025-08-29 AccNo: 0001683168-25-006537 Size: 1 MB

New Form F-1 - PURPLE BIOTECH LTD. Filed: 2025-08-29 AccNo: 0001213900-25-082116 Size: 1 MB

Edwards Lifesciences Corp - Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care

Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care

New New SEC Form - Altamira Therapeutics

Health Catalyst Announces Winners of the 2025 Catalyst Awards

New Form 8-K - iTeos Therapeutics, Inc. Filed: 2025-08-29 AccNo: 0001193125-25-192031 Size: 456 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 3.03: Material Modifications to Rights of Security Holders …

New Form SCHEDULE 13G - CEL SCI CORP Filed: 2025-08-29 AccNo: 0001641172-25-025900 Size: 6 KB

New Form SC 14D9/A - iTeos Therapeutics, Inc. Filed: 2025-08-29 AccNo: 0001193125-25-192007 Size: 17 KB

New Form SC TO-T/A - iTeos Therapeutics, Inc. Filed: 2025-08-29 AccNo: 0001140361-25-033301 Size: 179 KB

Pasithea Therapeutics Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference

Pasithea Therapeutics Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference

Hawkins, Inc. Expands Water Treatment Footprint with Acquisition of StillWaters Technology, Inc.

New Form PRE 14A - TALPHERA, INC. Filed: 2025-08-29 AccNo: 0001437749-25-027994 Size: 3 MB